Bacteroides thetaiotaomicron is a species that belongs to the Bacteroides fragilis group. It is one of the dominating species in colon microflora and, after B. fragilis, is the most frequently isolated anaerobic bacteria in clinical infections. The B. fragilis group species are among the most resistant ones of all anaerobes to antimicrobial agents, whereas the b-lactam antibiotics are the most widely used of all the groups of antimicrobials [1] [2] [3] . The targets of b-lactams are penicillin-binding proteins (PBPs), mainly D-alanyl-D-alanine transpeptidase and other cytoplasmic membrane proteins enrolled in peptidoglycan synthesis and turnover. To exert their effect, the b-lactams must reach the outside of the cytoplasmic membrane, where the PBPs are located. In gram-neg-
cron 1186 and 2877 from fecal samples in Huddinge University Hospital 1997. Strains 238 and 1186 were used as parent strains for selection of resistant mutants, named 238m and 1186m, respectively. B. thetaiotaomicron ATCC 29741 was included as a reference strain.
Selection of cefoxitin-resistant mutants.
The parent strains were cultured anaerobically overnight in supplemented brain-heart infusion (BHIS) broth [5] . An aliquot (100 mL) of each culture was inoculated onto an antibiotic sensitivity medium (ASM; AB Biodisk) agar plate that contained cefoxitin at a concentration equivalent to the MIC (16 mg/mL) of the strain. The plates were then incubated anaerobically for 72 h at 37ЊC. The survival colonies were subsequently plated onto gradient plates that contained cefoxitin ranging from 0 to 128 mg/mL. Colonies growing at the area with a high concentration of cefoxitin were transferred to new plates that contained the same concentration of antibiotic as did the area in the gradient plate where they were selected. After being cultured on the plates that contained cefoxitin at a certain concentration 3 times in succession, they were exposed to the next 2-fold higher concentration of cefoxitin [6] [7] [8] [9] .
Antimicrobial susceptibility tests. The MICs of 6 b-lactam agents (ampicillin, ampicillin-clavulanic acid, piperacillin, cefoperazone, cefoxitin, and imipenem) were determined by the agar dilution method on ASM agar (AB Biodisk) with the addition of 5% defibrinated horse blood. The inoculum was ∼10 5 cfu/spot, applied by a Steer replicator, and the strains were incubated in anaerobic jars for 48 h at 37ЊC [10] .
b-Lactamase. The presence of b-lactamase was detected by nitrocefin. One clear loop (1 mL) of bacteria was incubated with 100 mL of nitrocefin (1.5 mM) for 15 min at room temperature. The activity of b-lactamase was recorded on rank according to the change of color. The b-lactamase activity was too low to be detected quantitatively by spectrophotometry in strains 238, 238m, 1186, 1186m, and ATCC (American Type Culture Collection) 29741.
The production and preliminary characterization of b-lactamase produced by strain 2877 were performed as described elsewhere [11] . Strain 2877 was cultured in 1000 mL of prereduced BHIS broth at 37ЊC. The culture was harvested at maximum enzyme production during the late log phase (17 h) by centrifugation at 9000 g for 30 min at 4ЊC. The cells were then disrupted by sonication (4 cycles: time, 1 min; pulse, 1 s : 1 s; amplitude, 30%; and temperature, !5ЊC) (High Intensity Ultrasonic Processor; CiAB). The supernatant fraction was assayed for b-lactamase activity and used for inhibition studies.
b-Lactamase activity was assayed spectrophotometrically with nitrocefin (100 mM) in 50 mM sodium phosphate buffer (pH, 7.0; temperature, 30ЊC) as the substrate. One unit of blactamase was defined as the amount that formed 1.0 mmol of product per minute under these conditions. Clavulanic acid (300 mM) was preincubated at 30ЊC for different time periods (0.5-20 min) with the crude b-lactamase to study the inhibition of enzyme activity. The enzyme activity was also tested in the presence of 1 mM EDTA.
Preparation of envelope membrane. The strains were cultured in 1800 mL of prereduced BHIS broth at 37ЊC. The cultures were then harvested and sonicated as described above. After sonication, unbroken cells and debris were removed by centrifugation at 4000 g for 10 min at 4ЊC. Envelope membranes were concentrated by centrifugation at 100,000 g for 40 min at 4ЊC and were washed once in 10 mM sodium phosphate buffer (pH, 7.2). Membrane fractions were separated into aliquots and were frozen at Ϫ70ЊC until analyzed [2] . Strain 1186m was cultured in broth that contained cefoxitin at the concentration of 64 mg/mL, because the resistance was lost in absence of the antibiotic. No antibiotic pressure was loaded when other strains were cultured.
Preparation of biotinylated ampicillin (Bio-Amp). BioAmp was prepared according to the method of Dargis and Malouin [12] . In brief, NHS-LC-Biotin (Pierce) and ampicillin (Sigma) were incubated at a 5:1 ratio (20:4 mM) for 30 min at room temperature with gentle agitation. The reaction was then stopped by the addition of a 10-fold molar excess of glycine (200 mM) and incubated for another 30 min at room temperature with gentle agitation. Finally, the Bio-Amp was frozen in aliquots at Ϫ70ЊC at a final concentration of 750 mg/mL.
Labeling penicillin-binding proteins. Envelope membrane proteins (0.5 mg) were incubated with clavulanic acid at 3 mg/ mL and piperacillin or cefoxitin at serial increasing concentrations for 30 min at room temperature. These samples were then, in reaction volumes of 500 mL, incubated with Bio-Amp (45 mg/mL) for 30 min at room temperature. Membranes then were washed in 0.1 M phosphate buffer (pH, 7.2) and underwent centrifugation at 40,000 g for 40 min. Pellets were resuspended in 0.01 M phosphate buffer (pH, 7.2), and the inner membrane proteins were solubilized in 1% sodium-lauroylsarcosine for 20 min. Insoluble membranes were then removed by centrifugation at 40,000 g for 40 min. Supernatant fractions, which contained solubilized, labeled membrane proteins, were separated by 10% SDS-polyacrylamide gel electrophoresis (PAGE). After electrophoresis, proteins were transferred to nitrocellulose. The nitrocellulose sheets were then blocked at 4ЊC overnight in PBS-Tween (0.01 M PBS with 0.1% Tween-20) that contained 10% nonfat milk powder. The membranes were rinsed in PBS-Tween 3 times and then were incubated in 0.1% Tween-20, 20 mM Tris, and 137 mM NaCl (TTBS) that contained 1:1000 streptavidin-peroxidase conjugate (Calbiochem) for 1 h at room temperature [12, 13] . Finally, the membranes were washed in TTBS and were examined for luminescence according to the enhanced chemiluminescence protocols described by the manufacturer (Amersham Pharmacia Biotech AB). Outer membrane proteins. Cultures were grown in BHIS broth at 37ЊC anaerobically overnight. The optical density (lp 600 nm) of each culture was measured and adjusted to 0.9 by dilution with BHIS broth. Five milliliters of the adjusted bacterial suspension was centrifuged at 3000 g for 10 min at 4ЊC. The pellet was suspended in 1 mL of cold Tris-Mg buffer (10 mM Tris-HCl and 5 mM MgCl 2 [pH, 7.3]). The cells then were washed twice by centrifugation at 11,000 g for 5 min with TrisMg buffer and were sonicated (High Intensity Ultrasonic Processor, CiAB) by 2 cycles of the following program: time, 30 s; pulse, 5:1; and amplitude, 20%. The sonicates were briefly centrifuged to remove unbroken cells and debris. The supernatant was further centrifuged to get membrane pellets. The membrane pellets then were incubated with 2% sodium-lauroylsarcosine for 30 min at room temperature and were centrifuged at 17,000 g for 30 min at 4ЊC. The resulting pellets that contained OMPs were washed once with Tris-Mg buffer and were finally harvested by centrifugation. The OMPs were separated by 12.5% SDS-PAGE, and the gels were stained with Coomassie blue [14, 15] .
RESULTS

Selection of cefoxitin-resistant mutants.
Cefoxitin-resistant mutants 238m and 1186m, which originated from strains 238 and 1186, were isolated from plates that contained cefoxitin up to 128 and 256 mg/mL, respectively.
Antimicrobial susceptibility. The MICs for the investigated strains are summarized in table 1. The parent strains (238 and 1186) were susceptible to cefoxitin and other b-lactam antibiotics tested, except for ampicillin. Members of the B. fragilis group were presumed to be resistant to ampicillin. The MICs of cefoxitin against mutant strains were at least 16-fold higher compared with those of the parent strains. The susceptibilities to penicillins and cefoperazone were у4-fold reduced in strain 238m compared with that of its parent. Strain 238m was still considered susceptible to imipenem in spite of a 2-fold elevated MIC. Strain 1186m showed 2-4-fold decreased susceptibilities to other b-lactam antibiotics tested except for imipenem. Cefoxitin and piperacillin were 2 of the tested b-lactams, to which both mutants showed at least 4-fold decreased susceptibilities compared with their parents. Strain 2877 showed resistance or decreased susceptibilities to ampicillin, piperacillin, cefoperazone, and cefoxitin. The ampicillin resistance was reversed with the addition of clavulanic acid.
b-Lactamase. In general, B. fragilis group species are blactamase producers. The strains investigated in the present study also produced a certain amount of b-lactamase (table 1) , but the enzyme activity was too low to be detected quantitatively in strains other than strain 2877. It was found that the amounts of b-lactamases produced by strains 238 and 1186 were comparable to that produced by the type strain B. thetaiotaomicron ATCC 29741, and the b-lactamase production was not elevated in the mutant strains compared with the parent strains. In case of strain 2877, the specific b-lactamase activity from crude cell extracts was 0.13 U/mg of protein. The enzyme activity was inhibited by clavulanic acid but was not influenced by EDTA.
Penicillin-binding proteins. Strains 238 and 238m exhibited similar PBP patterns. However, antibiotic competition assays showed that the affinities for cefoxitin and piperacillin of PBP1 complex (∼86 kDa) and another PBP with a molecular weight of 72 kDa were decreased in strain 238m compared with strain 238 (figure 1). The IC 50 values are summarized in table 2.
In strains 1186 and 1186m, the expression of the PBP1a component (90 kDa) of PBP1 complex (85-90 kDa) was ∼60% reduced, whereas the PBP1b component (85 kDa) was ∼20% less expressed in strain 1186m compared with the parent strain. 
mg/mL. The arrows denote the 86-and 72-kDa PBPs, respectively. Meanwhile, the PBP2 (80 kDa) present in strain 1186 was missing in the mutant strain 1186m (figure 2). Because the major PBPs in strain 1186m were already 150% reduced or absent, the IC 50s of strains 1186 and 1186m were not calculated. With regard to strain 2877, a susceptible type strain of the same species (B. thetaiotaomicron ATCC 29741) was used as a reference in the PBP assays and after the OMP assay. From the PBP assay, it was found that the main target of cefoxitin and piperacillin was the PBP1 complex in both strains. The molecular weight of PBP1 complex differed slightly between the 2 strains. The PBP1 had a slightly higher molecular weight in strain 2877 (86-92 kDa) than in the reference strain (82-88 kDa). However, the affinity of cefoxitin or piperacillin for PBP1 was even higher in strain 2877 than in the reference strain ( figure 3) .
OMPs. The OMP profiles between the parent strains and the mutant strains varied mainly at the region of 37-40 kDa. An ∼37-kDa OMP, present in the parent strains (238 and 1186), was absent in the mutant strains (238m and 1186m) ( figure 4,  top) . Similarly, the 37-kDa OMP was also absent in strain 2877 compared with strains 238, 1186, and ATCC 29741 (figure 4). Other alterations, such as band intensity and band shift, were also observed.
DISCUSSION
In the present study, 2 cefoxitin-resistant mutants were obtained from clinical isolates of B. thetaiotaomicron by selection with increasing concentrations of cefoxitin. The mutant strains showed decreased susceptibilities not only to cefoxitin but also to other b-lactam antibiotics. Deficiency in PBPs and OMPs was observed in the resistant mutants, whereas the alteration of OMPs and production of b-lactamase were demonstrated in the clinical isolate B. thetaiotaomicron 2877, which had reduced susceptibility to b-lactams.
Selection of porin-deficient mutants and the association of loss of OMPs and increased resistance to b-lactam antibiotics have been reported in a variety of aerobic organisms, including Enterobacter cloacae, Klebsiella pneumoniae, and Shigella dysenteriae [6-8, 16, 17] . In case of B. fragilis group species, the discrepancy in OMP profiles between the laboratory mutants and their parent strains was not observed in the studies done by Piddock and Wise [15] , Wexler and Halebian [18] , and Yotsuji et al. [19] . In the present study, we found that the 2 mutants lost an ∼37-kDa OMP that was expressed in the parent strains and the type strain. Accordingly, this 37-kDa protein was also absent in the resistant strain 2877. In our survey on the OMP profiles of B. thetaiotaomicron strains, 2 clinical isolates were found to lack the 37-kDa OMP. One was strain 2877, which was a multiresistant strain with reduced susceptibilities to b-lactams, clindamycin (MIC, 164 mg/mL), and metronidazole (MIC, 8 mg/mL), and another (strain 259) showed reduced susceptibility to cefoxitin (MIC 32 mg/mL), although it was susceptible to other b-lactams tested. The OMP profile of strain 259 is included in figure 4 , middle. Taken together, the alteration of OMPs observed in the present study might be involved in the decreased susceptibility to b-lactams.
Shipman et al. [20] has recently described 4 OMPs involved in binding starch to the cell surface of B. thetaiotaomicron. However, no evidence is available with regard to the role of these OMPs in antibiotic diffusion.
Alterations in PBPs, mainly changes in PBP1 and/or PBP2, have been reported to be involved in non-b-lactamase-mediated cefoxitin resistance in cefoxitin-resistant mutants of B. fragilis group species [15, 18] . In the study by Piddock and Wise [15] , reduction in the affinity of PBP1 and/or PBP2 was observed in some of the laboratory-mutagenized strains of B. fragilis, which was believed to be correlated with a decrease in 1, 6 , and 7, 0; lanes 2 and 8, 0.5 mg/mL; lanes 3 and 9, 2 mg/mL; lanes 4 and 10, 8 mg/mL; and lanes 5 and 11, 32 mg/mL. B, Piperacillin competition assay. Lanes 1, 6, and 7, 0; lanes 2 and 8, 0.25 mg/mL; lanes 3 and 9, 0.5 mg/ mL; lanes 4 and 10, 1 mg/mL; and lanes 5 and 11, 2 mg/mL. The arrows denote the PBP1 complex. susceptibility to cefoxitin. In the present study, the affinities of PBP1 complex (86 kDa) for cefoxitin and piperacillin of strain B. thetaiotaomicron 238m were 1100-fold and ∼70-fold reduced, respectively, compared with those of its parent strain. It has been reported that the piperazine-penicillin piperacillin had enhanced activity against gram-negative bacilli primarily by its increased affinity for PBP3 [2] . Piperacillin, in that study, presented a high affinity for a 72-kDa PBP in the parent strain B. thetaiotaomicron 238 (IC 50 , 0.01 mg/mL). Thereby, the 72-kDa PBP could be regarded as PBP3 in B. thetaiotaomicron 238 and 238m. The PBP3 in mutant 238m had decreased affinities for cefoxitin and piperacillin, especially for piperacillin with a reduction magnitude of 1100-fold, compared with those of its parent. Accordingly, the affinity of PBP3 for cefoxitin was also decreased, although only 2-fold, in 3 of Piddock's B. fragilis mutants. In Wexler's study, the resistant mutant of Bacteroides distasonis differed from its parent by the absence of a labeled PBP band at 90 kDa (PBP1) and by the appearance of a new band with a molecular weight of 95 kDa. Similar to Wexler's finding, the mutant strain B. thetaiotaomicron 1186m in the present study presented a marked reduction of labeling to the PBP1a component (90 kDa) of PBP1 complex. The PBP2 (80 kDa) was absent, however, and no obvious new band appeared in the mutant 1186m. The PBP alterations presented by the 2 mutant strains in the present study were different. Strain 238m had decreased affinity in the normal PBPs, whereas loss and reduced expression of major PBPs were observed in strain 1186m. Both ways can cause decreased susceptibility to b-lactam agents. Therefore, alterations in the PBPs is 1 of the mechanisms involved in b-lactam resistance in these mutants.
The differences in the PBPs between strain 2877 and the reference strain could be considered as the strain to strain variability of PBPs. The antibiotic competition assays indicated that the PBP1 complex, the main target of b-lactam antibiotics, actually had higher affinities for piperacillin and cefoxitin in strain 2877 than in the reference strain. Therefore, alteration of PBPs does not contribute to the piperacillin and cefoxitin resistance in strain 2877.
Of interest, in strain 1186m, the alterations in both OMPs and PBPs were only produced when the cultures were given an antibiotic burden. Accordingly, 1186m lost the cefoxitin resistance from the third passage when being cultured on antibiotic-free blood agar plates. This phenomenon further supports the involvement of alterations of OMPs and PBPs in the resistance. However, the resistance of the other mutant (238m) was stable for at least 10 consecutive passages on media without antibiotic. These phenomena may indicate that the genetic determinants coding for the alterations in the cell walls in these mutants behave differently.
Resistance to b-lactam agents in anaerobic bacteria is generally considered to be mediated primarily by the production of b-lactamases. Enzymes capable of degrading cefoxitin have been reported [21] . However, some cefoxitin-resistant isolates have either very low levels of b-lactamases or do not degrade cefoxitin, even though they do possess b-lactamases [15, [21] [22] [23] . In the present study, the parent strains produced basal levels of b-lactamase whose activities were comparable to that of the susceptible type strain. No enhancement in b-lactamase activity was observed in the mutant strains. Therefore, non-blactamase-mediated mechanisms must have played an important role in the b-lactam resistance of these mutants, which has been indicated by the present study.
The specific b-lactamase activity of 0.13 U/mg of protein in strain 2877 was low when compared with enzyme levels reported elsewhere in b-lactam-resistant B. fragilis group strains [24] [25] [26] . The b-lactam-hydrolyzing activity was even much lower or undetectable when ampicillin, piperacillin, cefoperazone, or cefoxitin was used as the substrate instead of nitrocefin. Therefore, the b-lactam resistance in this strain cannot be fully explained by the production of b-lactamase. Alteration in PBPs is not a contributing factor to its resistance; therefore, it seems like another mechanism is acting alongside, and the altered OMPs are probably involved.
It has been known for decades that the main part (in some surveillance studies, up to 100%) of the B. fragilis group strains produce b-lactamase, but no regard has been paid to other resistance mechanisms or combination of mechanisms in studies that have dealt with great numbers of strains. This is probably due to practical problems. As a consequence, data on the prevalence of non-b-lactamase-mediated resistance in the B. fragilis group have not yet been available. Non-b-lactamase-mediated resistance in clinical isolates might cause clinical failures and would perhaps be a greater challenge to the clinician than the b-lactamase-mediated resistance, which in most cases can be obviated by the addition of a b-lactamase inhibitor.
Efflux has recently been suggested as an additional contributing factor to b-lactam resistance, mainly in Pseudomonas aeruginosa and also in Escherichia coli, Salmonella typhimurium, and Stenotrophomonas maltophilia [27] [28] [29] [30] [31] [32] [33] . The role of efflux in b-lactam resistance among anaerobes remains an area for further research.
In conclusion, the b-lactam-resistant mutants of B. thetaiotaomicron with deficiency in both PBPs and OMPs can be selected for by exposure to cefoxitin. Several mechanisms are involved in the b-lactam resistance in the investigated B. thetaiotaomicron strains.
